Recent Research | Page 10 | Aplastic Anemia and MDS International Foundation

Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Titlesort descending Original Publication Date Journal Bone Marrow Disease
Autoimmunity and Inflammation in Myelodysplastic Syndromes Jun 2016 Acta Haematol myelodysplastic syndromes (MDS)
Azacitidine in the management of patients with myelodysplastic syndromes. Dec 2012 Ther Adv Hematol myelodysplastic syndromes (MDS)
Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)-ViLen-01 protocol Aug 2016 Ann Hematol myelodysplastic syndromes (MDS)
Baseline characteristics and disease burden in patients in the international paroxysmal nocturnal hemoglobinuria registry Jan 2014 Haematologica paroxysmal nocturnal hemoglobinuria (PNH)
BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders. Sep 2013 Blood myelodysplastic syndromes (MDS)
Beyond hypomethylating agents failure in patients with myelodysplastic syndromes Dec 2013 Curr Opin Hematol myelodysplastic syndromes (MDS)
Bilateral central serous retinopathy in a patient with paroxysmal nocturnal hemoglobinuria treated with deferoxamine Jul 2016 Eur J Ophthalmol paroxysmal nocturnal hemoglobinuria (PNH)
Biomarkers for predicting clinical response to immunosuppressive therapy in aplastic anemia Apr 2016 Int J Hematol aplastic anemia
Biosimilar epoetin in elderly patients with low-risk myelodysplastic syndromes improves anemia, quality of life, and brain function Apr 2014 Ann Hematol myelodysplastic syndromes (MDS)
Blood consult: paroxysmal nocturnal hemoglobinuria and its complications. Sep 2013 Blood paroxysmal nocturnal hemoglobinuria (PNH)